Potential Roles of Innate Immune Chemokine and Cytokine Network on Lipopolysaccharide-Based Therapeutic Approach in Ovarian Cancer
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Ovarian cancer (OC), the deadliest gynecological cancer, results in poor overall survival, urgently requiring a novel therapeutic approach. As cumulative exposures to endotoxins decreased OC risk epidemiologically, we evaluated if LPS, a Toll-like receptor 4 agonist known as active component of endotoxins, could increase survival in the murine peritoneal dissemination model of SKOV-3 OC cells. LPS significantly increased the mean survival time of more than 116 days compared with 63 days in the control. Furthermore, no tumor burden was present in three mice among eight LPS-treated mice. SKOV-3 cells were not responsive to LPS and showed unaltered chemokine signature. Rather than direct effects to OC cells, LPS was found to increase proinflammatory chemokines and cytokines, such as CXCL1, CXCL8, TNF, and IL-1B, in innate immune system. Taken together, LPS is likely to potentiate the cytotoxic-related innate immunogenicity via proinflammatory chemokines and cytokines, which attenuates the peritoneal dissemination of OC.
Abstract
Ovarian cancer (OC), the deadliest gynecological cancer, results in poor overall survival, urgently requiring a novel therapeutic approach. As cumulative exposures to endotoxins decreased OC risk epidemiologically, we evaluated if LPS, a Toll-like receptor 4 agonist known as active component of endotoxins, could increase survival in the murine peritoneal dissemination model of SKOV-3 OC cells. LPS significantly increased the mean survival time of more than 116 days compared with 63 days in the control. Furthermore, no tumor burden was present in three mice among eight LPS-treated mice. SKOV-3 cells were not responsive to LPS and showed unaltered chemokine signature. Rather than direct effects to OC cells, LPS was found to increase proinflammatory chemokines and cytokines, such as CXCL1, CXCL8, TNF, and IL-1B, in innate immune system. Taken together, LPS is likely to potentiate the cytotoxic-related innate immunogenicity via proinflammatory chemokines and cytokines, which attenuates the peritoneal dissemination of OC.
참고문헌 (48)
- Torre LA, "Ovarian cancer statistics, 2018", CA Cancer J Clin, 68, pp.284~296 (2018)
- Doubeni CA, "Diagnosis and management of ovarian cancer", Am Fam Physician, 93, pp.937~944 (2016)
- Siegel RL, "Cancer statistics, 2018", CA Cancer J Clin, 68, pp.7~30 (2018)
- Rojas V, "Molecular characterization of epithelial ovarian cancer: implications for diagnosis and treatment", Int J Mol Sci, 17, pp.E2113~ (2016)
- Kurman RJ, "The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded", Am J Pathol, 186, pp.733~747 (2016)
- Cancer Genome Atlas Research Network, "Integrated genomic analyses of ovarian carcinoma", Nature, 474, pp.609~615 (2011)
- Son DS, "Inhibitory effect of tumor suppressor p53 on proinflammatory chemokine expression in ovarian cancer cells by reducing proteasomal degradation of IκB", PLoS One, 7, pp.e51116~ (2012)
- Dong YL, "CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signaling", PLoS One, 8, pp.e83789~ (2013)
- Ignacio RM, "NF-κB-mediated CCL20 reigns dominantly in CXCR2-driven ovarian cancer progression", PLoS One, 11, pp.e0164189~ (2016)
- Rosa Mistica C. Ignacio, "Chemokine Network and Overall Survival in TP53 Wild-Type and Mutant Ovarian Cancer", Immune Network, 18(4), pp.1~13 (2018), 대한면역학회[DOI]
- Zielen S, "Lipopolysaccharide challenge: immunological effects and safety in humans", Expert Rev Clin Immunol, 11, pp.409~418 (2015)
- Lundin JI, "Endotoxin and cancer", Environ Health Perspect, 117, pp.1344~1350 (2009)
- Galluzzi L, "Trial watch: experimental Toll-like receptor agonists for cancer therapy", OncoImmunology, 1, pp.699~716 (2012)
- Mastrangelo G, "Endotoxin and cancer chemo-prevention", Cancer Epidemiol, 37, pp.528~533 (2013)
- Son DS, "Keratinocyte chemoattractant (KC)", human growth-regulated oncogene (GRO) chemokines and pro-inflammatory chemokine networks in mouse and human ovarian epithelial cancer cells, 2007, pp.6, 1302~1312
- Jia D, "Inflammation is a key contributor to ovarian cancer cell seeding", Sci Rep, 8, pp.12394~ (2018)
- Savant SS, "The role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial ovarian cancer", Cancers (Basel), 10, pp.E251~ (2018)
- Son DS, "Characteristics of chemokine signatures elicited by EGF and TNF in ovarian cancer cells", J Inflamm (Lond), 10, pp.25~ (2013)
- Perez-Llamas C, "Gitools: analysis and visualisation of genomic data using interactive heat-maps", PLoS One, 6, pp.E19541~ (2011)
- Wernli KJ, "Occupational exposures and ovarian cancer in textile workers", Epidemiology, 19, pp.244~250 (2008)
- Wernli KJ, "Cancer among women textile workers in Shanghai, China: overall incidence patterns, 1989–1998", Am J Ind Med, 44, pp.595~599 (2003)
- Applebaum KM, "Evidence of a paradoxical relationship between endotoxin and lung cancer after accounting for left truncation in a study of Chinese female textile workers", Occup Environ Med, 70, pp.709~715 (2013)
- Agalliu I, "Risk of lung cancer in relation to contiguous windows of endotoxin exposure among female textile workers in Shanghai", Cancer Causes Control, 22, pp.1397~1404 (2011)
- Lenters V, "Endotoxin exposure and lung cancer risk: a systematic review and meta-analysis of the published literature on agriculture and cotton textile workers", Cancer Causes Control, 21, pp.523~555 (2010)
- Astrakianakis G, "Lung cancer risk among female textile workers exposed to endotoxin", J Natl Cancer Inst, 99, pp.357~364 (2007)
- Lange JH, "Endotoxin exposure and lung cancer mortality by type of farming: is there a hidden dose-response relationship", Ann Agric Environ Med, 10, pp.229~232 (2003)
- Mastrangelo G, "Reduced lung cancer mortality in dairy farmers: is endotoxin exposure the key factor", Am J Ind Med, 30, pp.601~609 (1996)
- Merchant JA, "Mortality of employees of two cotton mills in North Carolina", Chest, 79, pp.6S~11S (1981)
- Hodgson JT, "Mortality of workers in the British cotton industry in 1968-1984", Scand J Work Environ Health, 16, pp.113~120 (1990)
- Levin LI, "Decreased risk of lung cancer in the cotton textile industry of Shanghai", Cancer Res, 47, pp.5777~5781 (1987)
- Szeszenia-Dabrowska N, "Mortality in the cotton industry workers: results of a cohort study", Int J Occup Med Environ Health, 12, pp.143~158 (1999)
- Mastrangelo G, "Lung and other cancer site mortality in a cohort of Italian cotton mill workers", Occup Environ Med, 65, pp.697~700 (2008)
- Kuzmickiene I, "Lung cancer risk among textile workers in Lithuania", J Occup Med Toxicol, 2, pp.14~ (2007)
- Blair A, "Mortality among participants in the agricultural health study", Ann Epidemiol, 15, pp.279~285 (2005)
- Laakkonen A, "Cancer incidence among Finnish farmers, 1995–2005", Scand J Work Environ Health, 34, pp.73~79 (2008)
- Mastrangelo G, "Lung cancer risk: effect of dairy farming and the consequence of removing that occupational exposure", Am J Epidemiol, 161, pp.1037~1046 (2005)
- Pukkala E, "Cancer incidence among Finnish farmers, 1979–93", Cancer Causes Control, 8, pp.25~33
- Reif J, "Cancer risks in New Zealand farmers", Int J Epidemiol, 18, pp.768~774 (1989)
- Schroeder JC, "Mortality studies of machining fluid exposure in the automobile industry IV: a case-control study of lung cancer", Am J Ind Med, 31, pp.525~533 (1997)
- Mastrangelo G, "Epidemiologic evidence of cancer risk in textile industry workers: a review and update", Toxicol Ind Health, 18, pp.171~181 (2002)
- Checkoway H, "Possible pro-carcinogenic association of endotoxin on lung cancer among Shanghai women textile workers", Br J Cancer, 111, pp.603~607 (2014)
- Kuzmickiene I, "Cancer incidence in the workers cohort of textile manufacturing factory in Alytus, Lithuania", J Occup Environ Med, 46, pp.147~153 (2004)
- Baccarelli A, "Risk of lung cancer from exposure to dusts and fibers in Leningrad Province, Russia", Am J Ind Med, 49, pp.460~467 (2006)
- Wong EY, "Reproductive history, occupational exposures, and thyroid cancer risk among women textile workers in Shanghai, China", Int Arch Occup Environ Health, 79, pp.251~258 (2006)
- Berek JS, "Synergistic effects of combination sequential immunotherapies in a murine ovarian cancer model", Cancer Res, 45, pp.4215~4218 (1985)
- Vindevogel E, "The use of Toll-like receptor 4 agonist to reshape the immune signature in ovarian cancer", Anticancer Res, 36, pp.5781~5792 (2016)
- d'Adhemar CJ, "The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer", PLoS One, 9, pp.e100816~ (2014)
- Walana W, "IL-8 analogue CXCL8 (3-72) K11R", G31P, modulates LPS-induced inflammation via AKT1-NF-kβ and ERK1, Hum Immunol, pp.2018, 79[DOI]
